- Home
- SYBT vs LIVN Comparison
SYBT vs LIVN Comparison
Compare SYBT & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBT
- LIVN
- Stock Information
- Founded
- SYBT 1904
- LIVN 1987
- Country
- SYBT United States
- LIVN United Kingdom
- Employees
- SYBT N/A
- LIVN N/A
- Industry
- SYBT Major Banks
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SYBT Finance
- LIVN Health Care
- Exchange
- SYBT Nasdaq
- LIVN Nasdaq
- Market Cap
- SYBT 2.2B
- LIVN 2.1B
- IPO Year
- SYBT N/A
- LIVN 1993
- Fundamental
- Price
- SYBT $75.88
- LIVN $45.95
- Analyst Decision
- SYBT Hold
- LIVN Strong Buy
- Analyst Count
- SYBT 3
- LIVN 7
- Target Price
- SYBT $80.33
- LIVN $59.29
- AVG Volume (30 Days)
- SYBT 101.6K
- LIVN 676.1K
- Earning Date
- SYBT 07-23-2025
- LIVN 07-30-2025
- Dividend Yield
- SYBT 1.65%
- LIVN N/A
- EPS Growth
- SYBT 16.29
- LIVN N/A
- EPS
- SYBT 4.14
- LIVN N/A
- Revenue
- SYBT $353,277,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- SYBT $14.39
- LIVN $8.10
- Revenue Next Year
- SYBT $5.04
- LIVN $5.76
- P/E Ratio
- SYBT $18.14
- LIVN N/A
- Revenue Growth
- SYBT 8.97
- LIVN 7.62
- 52 Week Low
- SYBT $45.26
- LIVN $32.48
- 52 Week High
- SYBT $79.85
- LIVN $57.35
- Technical
- Relative Strength Index (RSI)
- SYBT 59.34
- LIVN 65.65
- Support Level
- SYBT $72.44
- LIVN $42.44
- Resistance Level
- SYBT $74.65
- LIVN $43.61
- Average True Range (ATR)
- SYBT 2.37
- LIVN 1.01
- MACD
- SYBT -0.18
- LIVN 0.02
- Stochastic Oscillator
- SYBT 90.32
- LIVN 96.35
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.